Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis.

Michelena J, Alonso C, Martínez-Arranz I, Altamirano J, Mayo R, Sancho-Bru P, Bataller R, Ginès P, Castro A, Caballería J.

Ann Hepatol. 2019 Jan - Feb;18(1):144-154. doi: 10.5604/01.3001.0012.7906.

2.

A Slow-Digesting Carbohydrate Diet during Rat Pregnancy Protects Offspring from Non-Alcoholic Fatty Liver Disease Risk through the Modulation of the Carbohydrate-Response Element and Sterol Regulatory Element Binding Proteins.

Salto R, Manzano M, Girón MD, Cano A, Castro A, Vílchez JD, Cabrera E, López-Pedrosa JM.

Nutrients. 2019 Apr 14;11(4). pii: E844. doi: 10.3390/nu11040844.

3.

Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis.

Michelena J, Alonso C, Martínez-Arranz I, Altamirano J, Mayo R, Sancho-Bru P, Bataller R, Ginès P, Castro A, Caballería J.

Ann Hepatol. 2018 Dec 13;18(1):144-154. doi: 10.5604/01.3001.0012.7906.

4.

Feeding a slowly digestible carbohydrate diet during pregnancy of insulin-resistant rats prevents the excess of adipogenesis in their offspring.

Martin MJ, Manzano M, Bueno-Vargas P, Rueda R, Salto R, Giron MD, Vilchez JD, Cabrera E, Cano A, Castro A, Ramirez-Tortosa C, Lopez-Pedrosa JM.

J Nutr Biochem. 2018 Nov;61:183-196. doi: 10.1016/j.jnutbio.2018.05.018. Epub 2018 Jun 12.

5.

Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts.

Mayo R, Crespo J, Martínez-Arranz I, Banales JM, Arias M, Mincholé I, Aller de la Fuente R, Jimenez-Agüero R, Alonso C, de Luis DA, Vitek L, Stritesky J, Caballería J, Romero-Gómez M, Martín-Duce A, Mugüerza Huguet JM, Busteros-Moraza JI, Idowu MO, Castro A, Martínez-Chantar ML, Ortiz P, Bruha R, Lu SC, Bedossa P, Noureddin M, Sanyal AJ, Mato JM.

Hepatol Commun. 2018 May 4;2(7):807-820. doi: 10.1002/hep4.1188. eCollection 2018 Jul.

6.

Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression.

Clos-Garcia M, Loizaga-Iriarte A, Zuñiga-Garcia P, Sánchez-Mosquera P, Rosa Cortazar A, González E, Torrano V, Alonso C, Pérez-Cormenzana M, Ugalde-Olano A, Lacasa-Viscasillas I, Castro A, Royo F, Unda M, Carracedo A, Falcón-Pérez JM.

J Extracell Vesicles. 2018 May 7;7(1):1470442. doi: 10.1080/20013078.2018.1470442. eCollection 2018.

7.

A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients.

Cano A, Mariño Z, Millet O, Martínez-Arranz I, Navasa M, Falcón-Pérez JM, Pérez-Cormenzana M, Caballería J, Embade N, Forns X, Bosch J, Castro A, Mato JM.

Sci Rep. 2017 Sep 5;7(1):10497. doi: 10.1038/s41598-017-10807-y.

8.

Metabolomic signatures associated with disease severity in multiple sclerosis.

Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jan 27;4(2):e321. doi: 10.1212/NXI.0000000000000321. eCollection 2017 Mar.

9.

Metabolically active extracellular vesicles released from hepatocytes under drug-induced liver-damaging conditions modify serum metabolome and might affect different pathophysiological processes.

Royo F, Palomo L, Mleczko J, Gonzalez E, Alonso C, Martínez I, Pérez-Cormenzana M, Castro A, Falcon-Perez JM.

Eur J Pharm Sci. 2017 Feb 15;98:51-57. doi: 10.1016/j.ejps.2016.10.020. Epub 2016 Oct 19.

PMID:
27771515
10.

Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy.

Embade N, Mariño Z, Diercks T, Cano A, Lens S, Cabrera D, Navasa M, Falcón-Pérez JM, Caballería J, Castro A, Bosch J, Mato JM, Millet O.

PLoS One. 2016 May 9;11(5):e0155094. doi: 10.1371/journal.pone.0155094. eCollection 2016.

11.

Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension.

Seijo S, Lozano JJ, Alonso C, Miquel R, Berzigotti A, Reverter E, Turon F, Martínez-Chantar ML, Castro A, Mato JM, Hernández-Gea V, Bosch J, García-Pagán JC.

Liver Int. 2016 Jul;36(7):1051-8. doi: 10.1111/liv.12972. Epub 2015 Oct 27.

PMID:
26394550
12.

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer.

Barbier-Torres L, Delgado TC, García-Rodríguez JL, Zubiete-Franco I, Fernández-Ramos D, Buqué X, Cano A, Gutiérrez-de Juan V, Fernández-Domínguez I, Lopitz-Otsoa F, Fernández-Tussy P, Boix L, Bruix J, Villa E, Castro A, Lu SC, Aspichueta P, Xirodimas D, Varela-Rey M, Mato JM, Beraza N, Martínez-Chantar ML.

Oncotarget. 2015 Feb 10;6(4):2509-23.

13.

Metabolomics discloses potential biomarkers for the noninvasive diagnosis of idiopathic portal hypertension.

Seijo S, Lozano JJ, Alonso C, Reverter E, Miquel R, Abraldes JG, Martinez-Chantar ML, Garcia-Criado A, Berzigotti A, Castro A, Mato JM, Bosch J, Garcia-Pagan JC.

Am J Gastroenterol. 2013 Jun;108(6):926-32. doi: 10.1038/ajg.2013.11. Epub 2013 Feb 19.

PMID:
23419380
14.

Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease.

Vazquez-Chantada M, Gonzalez-Lahera A, Martinez-Arranz I, Garcia-Monzon C, Regueiro MM, Garcia-Rodriguez JL, Schlangen KA, Mendibil I, Rodriguez-Ezpeleta N, Lozano JJ, Banasik K, Justesen JM, Joergensen T, Witte DR, Lauritzen T, Hansen T, Pedersen O, Veyrie N, Clement K, Tordjman J, Tran A, Le Marchand-Brustel Y, Buque X, Aspichueta P, Echevarria-Uraga JJ, Martin-Duce A, Caballeria J, Gual P, Castro A, Mato JM, Martinez-Chantar ML, Aransay AM.

Hepatology. 2013 Feb;57(2):505-14. doi: 10.1002/hep.26052. Epub 2012 Nov 27.

PMID:
22961556
15.

Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

Barr J, Vázquez-Chantada M, Alonso C, Pérez-Cormenzana M, Mayo R, Galán A, Caballería J, Martín-Duce A, Tran A, Wagner C, Luka Z, Lu SC, Castro A, Le Marchand-Brustel Y, Martínez-Chantar ML, Veyrie N, Clément K, Tordjman J, Gual P, Mato JM.

J Proteome Res. 2010 Sep 3;9(9):4501-12. doi: 10.1021/pr1002593.

16.

Sequence polymorphisms of the mtDNA control region in a human isolate: the Georgians from Swanetia.

Alfonso-Sánchez MA, Martínez-Bouzas C, Castro A, Peña JA, Fernández-Fernández I, Herrera RJ, de Pancorbo MM.

J Hum Genet. 2006;51(5):429-39. Epub 2006 Apr 1.

PMID:
16583128
17.

Ancestral origins of the prion protein gene D178N mutation in the Basque Country.

Rodríguez-Martínez AB, Barreau C, Coupry I, Yagüe J, Sánchez-Valle R, Galdós-Alcelay L, Ibáñez A, Digón A, Fernández-Manchola I, Goizet C, Castro A, Cuevas N, Alvarez-Alvarez M, de Pancorbo MM, Arveiler B, Zarranz JJ.

Hum Genet. 2005 Jun;117(1):61-9. Epub 2005 Apr 2.

PMID:
15806397
18.

Results of the GEP-ISFG collaborative study on two Y-STRs tetraplexes: GEPY I (DYS461, GATA C4, DYS437 and DYS438) and GEPY II (DYS460, GATA A10, GATA H4 and DYS439).

Sánchez-Diz P, Gusmão L, Beleza S, Benítez-Páez A, Castro A, García O, Solla LP, Geada H, Martín P, Martínez-Jarreta B, de Fátima Pinheiro M, Raimondi E, Silva de la Fuente SM, Vide MC, Whittle MR, Zarrabeitia MT, Carracedo A, Amorim A; GEP-ISFG.

Forensic Sci Int. 2003 Aug 12;135(2):158-62.

PMID:
12927418
19.

Results of the 1999-2000 collaborative exercise and proficiency testing program on mitochondrial DNA of the GEP-ISFG: an inter-laboratory study of the observed variability in the heteroplasmy level of hair from the same donor.

Alonso A, Salas A, Albarrán C, Arroyo E, Castro A, Crespillo M, di Lonardo AM, Lareu MV, Cubría CL, Soto ML, Lorente JA, Semper MM, Palacio A, Paredes M, Pereira L, Lezaun AP, Brito JP, Sala A, Vide MC, Whittle M, Yunis JJ, Gómez J.

Forensic Sci Int. 2002 Jan 24;125(1):1-7.

PMID:
11852196

Supplemental Content

Loading ...
Support Center